Joanne M. Donovan

CMO · Edgewise Therapeutics

Joanne M. Donovan (CMO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Edgewise Therapeutics, Inc. (EWTX). The largest single filing was $2.1M of EWTX (55,230 sh across 2 lots, as filed), executed May 4. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 5 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$4.6M

shares × price, as filed

Last traded

Aug 13

Filed Aug 14

Median ADV $64.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $5.3M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names

EWTX

Edgewise Therapeutics, Inc. EWTX · 0 buys · 6 sells 6 filings

Recent filings

EWTXSALE Edgewise Therapeutics, Inc. View filing → $372K
8,537 sh across 3 lots
Exec Aug 12
Filed Aug 14 · 4:54 PM ET EWTXSALE Edgewise Therapeutics, Inc. View filing → $2.1M
55,230 sh across 2 lots
Exec May 4
Filed May 5 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. View filing → $926K
28,662 sh × $32.31
Exec Apr 1
Filed Apr 2 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. View filing → $685K
21,338 sh × $32.12
Exec Mar 31
Filed Mar 31 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. View filing → $507K
16,358 sh across 2 lots
Exec Mar 27
Filed Mar 30 · 5:30 PM ET EWTXSALE Edgewise Therapeutics, Inc. View filing → $691K
25,000 sh × $27.63
Exec Jan 28 2025
Filed Jan 30 2025 · 5:30 PM ET